Massachusetts-based tech company Revvity has launched a new tool to remove a data entry chore from clinical laboratories. | ...

Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today that ...

Early detection is critical when it comes to curing diseases like cancer, but not everyone has easy access to screening tools ...

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented ...

It is helpful that the state began reporting scores in a new manner this year, which clarifies what ... (it) actually means ...

Cancer affects everyone. Either you’ve personally battled it, know someone who has, or have lost a loved one to this disease.

This review covers advancements in cancer detection using deep learning, focusing on various imaging techniques. The research ...

Color blindness is a condition where individuals struggle to distinguish certain colors, most commonly red and green. It ...

Neglected tropical diseases refer to a group of ailments that affect millions of people globally, often in poverty-stricken areas of the world, and yet don't receive the scientific attention they ...

The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.

According to a new study from scientists at The University of Texas at Arlington, Chan-Zuckerberg Biohub, and Stanford ...